Strauchen J A
Lancet. 1976 Sep 11;2(7985):545-7. doi: 10.1016/s0140-6736(76)91795-5.
A patient with otherwise typical addisonian pernicious anaemia and serum anti-intrinsic-factor antibody failed to respond to oral intrinsic factor on repeated testing during three years of therapy with parenteral vitamin B 12. There was no evidence of generalised malaborption. To test the hypothesis that binding of intrinsic factor to gut secretory antibody was responsible, an "augmented" Schilling test was devised using eight times the usual dose of intrinsic factor. This increased dose of intrinsic factor resulted in normal absorption of the test dose of vitamin B 12 confirming the diagnosis. It is suggested that the augmented Schilling test may be useful in the diagnosis of the occasional patient with features of pernicious anaemia who fails to respond to conventional doses of intrinsic factor in the Schilling test.
一名患有典型艾迪生病恶性贫血且血清抗内因子抗体呈阳性的患者,在接受胃肠外维生素B12治疗三年期间,多次重复检测显示口服内因子均无反应。没有证据表明存在全身性吸收不良。为了验证内因子与肠道分泌抗体结合是导致该情况的假设,设计了一种“强化”希林试验,使用通常剂量八倍的内因子。这种增加剂量的内因子使维生素B12试验剂量的吸收恢复正常,从而确诊。建议强化希林试验可能有助于诊断偶尔出现的具有恶性贫血特征但在希林试验中对常规剂量内因子无反应的患者。